Aptar Pharma to launch PureHale and showcase its portfolio of connected devices at CPhI Worldwide

Aptar Pharma, a leading drug delivery systems provider, is pleased to showcase its commitment to meeting new market trends at CPhI Worldwide this year.

The world’s largest pharma trade show, held 9 – 11 October in Madrid, will see more than 100,000 pharmaceutical professionals coming together for exhibitions, conferences and online communities, and this year Aptar Pharma will be showcasing an industry first with its PureHale device – a new portable drug delivery device designed for upper respiratory care – at stand 4D10.

In addition to PureHale, Aptar Pharma will also reveal:

  • A range of new connected drug delivery devices designed to help increase dose adherence and improve patient health outcomes
  • A portfolio of gamma-sterilized drug delivery components to reduce bioburden
  • Aptar Pharma’s Support Services initiative, a portfolio of stage-specific development packages to help customers in their journey from molecule to market

“Through a wide range of consulting and services, Aptar Pharma innovates around delivery routes, effective drug delivery, testing and regulatory requirements with partners ranging from small-scale R&D firms to the largest international pharmaceutical companies. We look forward to launching our Support Services initiative at CPhI, and working with our customers to meet their development needs.”

– Guillaume Brouet, Vice President Analytical, Regulatory and Scientific Affairs at Aptar Pharma

Along with showcasing its range of innovative drug delivery devices that address nasal, pulmonary, eye care, injectables and dermal drug delivery routes at Aptar Pharma’s exhibit stand, the company will also be sharing various new solutions in prescription and over-the-counter treatments.

Furthermore, Aptar Pharma executives will be delivering three Pharma Insight Briefings outlining the latest trends, technology and product innovations:
“Debunking the leachable myths of gamma sterilization: A migration study of steam vs gamma”

Julie D. Suman, R.Ph., Ph.D., President of Next Breath, a division of Aptar Pharma, Tuesday 9 October, 11:50-12:20

Julie Suman will present a migration study commissioned by Aptar Pharma to assess the impact of both steam sterilization and gamma sterilization on leachable profiles.

“Portable care for your respiratory tract: Exploring new technology platforms”
Guenter Nadler, Director Business Development, Aptar Pharma
Tuesday 9 October, 12:30-13:00

Guenter Nadler will discuss new trends in treating upper respiratory tract issues naturally,
including new respiratory technology platforms that will meet new market needs.

“Building a connected devices eco-system for digital medicines”
Sai Shankar, Director Business Development, Aptar Pharma
Wednesday 10 October, 13:50-14:20
Sai Shankar will highlight the need for a digital medicine eco-system to ensure connected devices are fully optimised through patient-centric design, secure data collection and management, and cross-platform interoperability.

Aptar Pharma’s team of experts will be on hand at our booth 4D10 to explain and demonstrate their latest drug delivery technologies and to discuss ways they can partner with customers to ensure their drug delivery challenges are met.

About Aptar Pharma
Aptar Pharma is part of AptarGroup, Inc. , a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America. For more information, visit aptar.com/pharma.